Company intelligence / Profile preview

Abram Scientific

South San Francisco, California, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Abram Scientific is developing CoagCare, a portable, strip-based viscoelastic point-of-care blood coagulation diagnostic system intended to deliver a full viscoelastic curve and thromboelastography-like parameters in under 10 minutes, supported by multiple NSF SBIR Phase I and II grants and US Army funding; products are not yet described as commercially launched.[3][4]

Therapeutic areas: HematologyCardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

National Science Foundation (SBIR Phase I and II funding partner)[4]US Army medical research funding for portable viscoelastic coagulation platform[3][4]

Beyond the preview

Go deeper on Abram Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abram Scientific.

Explore the full profile